Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece

OBJECTIVES: This study was designed to assess the cost-effectiveness of vildagliptin versus glimepiride as add-on to metformin in the management of type 2 diabetes mellitus (T2DM) patients in the Greek healthcare setting. METHODS: A cost-effectiveness model was designed, using MS Excel, to compare t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kousoulakou, Hara, Hatzikou, Magdalini, Baroutsou, Varvara, Yfantopoulos, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586069/
https://www.ncbi.nlm.nih.gov/pubmed/28904527
http://dx.doi.org/10.1186/s12962-017-0082-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586069/
https://www.ncbi.nlm.nih.gov/pubmed/28904527
http://dx.doi.org/10.1186/s12962-017-0082-7

Ejemplares similares